AbbVie ABBV
NYSE ABBV
$276.48 +4.06 (+1.49%)
At close: Oct 9, 2026 · 4:00 PM EDT

AbbVie (ABBV) Other Accumulated Expenses (2012 - 2015)

Updated

AbbVie (ABBV) posted Other Accumulated Expenses of $2.54 billion for Q4 2015, up 31.5% from $1.93 billion a year earlier.

Analysis

AbbVie (ABBV) Other Accumulated Expenses (2012 - 2015) Analysis & Trends

Since Q4 2012, AbbVie has reported Other Accumulated Expenses for 4 quarters.

  • Annual Other Accumulated Expenses shows a three-year compound annual growth rate of 14.0% (FY2012 to FY2015).
  • In prior years, AbbVie's Other Accumulated Expenses was $1.93 billion in FY2014 (+26.3%), $1.53 billion in FY2013 (-10.9%) and $1.72 billion in FY2012.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,109.58 Bn 1,078.16 Bn 19.71 Bn
2 Johnson & Johnson 630.16 Bn 548.69 Bn 17.26 Bn
3 AbbVie 488.57 Bn 461.73 Bn 12.70 Bn
4 Merck 359.15 Bn 313.58 Bn 12.21 Bn
5 Novartis Ag 274.32 Bn 238.71 Bn 11.24 Bn
6 Astrazeneca 246.73 Bn 220.50 Bn 12.86 Bn
7 Amgen 224.28 Bn 179.68 Bn 7.24 Bn
8 Gilead Sciences 187.60 Bn 161.71 Bn 6.22 Bn
9 Pfizer 161.13 Bn 108.08 Bn 10.94 Bn
10 Vertex Pharmaceuticals 129.23 Bn 101.23 Bn 2.84 Bn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2015 2.54 Bn
Dec 31, 2014 1.93 Bn
Dec 31, 2013 1.53 Bn
Dec 31, 2012 1.72 Bn
API Access

AbbVie Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=ABBV&period=max&api_key=YOUR_API_KEY